<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47682">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02485457</url>
  </required_header>
  <id_info>
    <org_study_id>2014/17</org_study_id>
    <nct_id>NCT02485457</nct_id>
  </id_info>
  <brief_title>Validation of Nicom Device to Measure Stoke Volume Variation</brief_title>
  <acronym>NICOM-VAL</acronym>
  <official_title>Validation of NICOM for the Detection of Modification of Stroke Volume</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the ability of NICOM (Noninvasive cardiac output
      monitor) to detect stroke volume variation induced by leg raising or fluid expansion during
      surgery
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke volume variation</measure>
    <time_frame>6 hours</time_frame>
    <description>Stroke volumes measured by esophageal Doppler and by Nicom: at baseline, after leg passive rising, and after volume loading</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Low volume</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The protocol will follow the following steps :
basal measurements (heart rate, arterial pressure, stroke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)
followed by passive leg rising and additional measurements (heart rate, arterial pressure, stoke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)
second basal measurements (heart rate, arterial pressure, stoke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)
followed by low volume loading (250 ml of Ringer solution) and additional measurements (heart rate, arterial pressure, stoke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High volume</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The protocol will follow the following steps :
basal measurements (heart rate, arterial pressure, stroke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)
followed by passive leg rising and additional measurements (heart rate, arterial pressure, stoke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)
second basal measurements (heart rate, arterial pressure, stoke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)
followed by low volume loading (500 ml of Ringer solution) and additional measurements (heart rate, arterial pressure, stoke volume estimated by esophageal Doppler, stoke volume estimated by Nicom)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Volume loading</intervention_name>
    <description>Volume loading with Ringer Lactate</description>
    <arm_group_label>Low volume</arm_group_label>
    <arm_group_label>High volume</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer solution</intervention_name>
    <arm_group_label>Low volume</arm_group_label>
    <arm_group_label>High volume</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing general anesthesia with an expected duration exceeding two hours

          -  gastrointestinal surgery, urological or gynecological surgery.

        Exclusion Criteria:

          -  Difficulty of venous access.

          -  Contraindication for the use of oesophageal Doppler

          -  Contraindication for the use of Nicom

          -  Contraindication for the use of bispectral index

          -  Pregnant or lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc Fischler</last_name>
    <phone>0609687854</phone>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Beaujon</name>
      <address>
        <city>Clichy</city>
        <state>Hauts de Seine</state>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Josserand, MD</last_name>
      <phone>40875911</phone>
      <phone_ext>00331</phone_ext>
      <email>julien.josserand@bjn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Julien Josserand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne Gayat, MD</last_name>
      <phone>49956565</phone>
      <phone_ext>00331</phone_ext>
      <email>etienne.gayat@9online.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marc Fischler</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Fischler, MD</last_name>
      <phone>0609687854</phone>
      <email>m.fischler@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 29, 2016</lastchanged_date>
  <firstreceived_date>June 26, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
